<template>
  <div class="container">
    <h2>ABOUT ALAXIA</h2>
    <br />
    <p>
      Alaxia is a French private biotech company developing therapeutic
      solutions for respiratory diseases based on its proprietary peroxidase
      platform. The most advanced drug candidate, ALX-009, is an antimicrobial
      innovative compound aiming at treating cystic fibrosis, including the most
      resistant bacterial strains.
    </p>
    <br />
    <br />
    <h2>ALX-009 Cystic Fibrosis</h2>
    <br />
    <p>
      Targets multi-drug-resistant (MDR) bacterial infections not treatable by
      current antibiotic therapies. Ready-to-inhale combination of two
      endogenous substances contribution to the innate immune system response.
      Innovative mode of action: Activity unaffected by CF patientâ€™s sputum and
      no emergence of bacterial resistance.
    </p>
    <br />
    <br />
    <a
      target="_blank"
      href="https://vimeo.com/user129176471/review/490746629/a318241b90"
      ><img src="../assets/about_video.png" alt=""
    /></a>
  </div>
</template>

<script>
export default {};
</script>

<style lang="scss" scoped>
h2,
p {
  text-align: left;
  color: #025293;
}
p:nth-child(5) {
  font-weight: bold;
}
p:nth-child(3) {
  text-align: justify;
}
p:nth-child(8) {
  text-align: justify;
}
img {
  width: 100%;
}
</style>
